Dauer, Patricia
Sharma, Nikita S.
Gupta, Vineet K.
Durden, Brittany
Hadad, Roey
Banerjee, Santanu
Dudeja, Vikas
Saluja, Ashok
Banerjee, Sulagna
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health (R01-CA184274)
Foundation for the National Institutes of Health (R01-CA170946, R01-CA124723)
Article History
Received: 8 October 2018
Revised: 25 January 2019
Accepted: 28 January 2019
First Online: 12 February 2019
Conflict of interest
: University of Minnesota has a patent for Minnelide, which has been licensed to Minneamrita Therapeutics, LLC. AKS is the co-founder and the Chief Scientific Officer of this company. SB is a consultant with Minneamrita Therapeutics LLC and this relationship is managed by University of Miami. The remaining authors declare that they have no conflict of interest.